CIK: 0001540951 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 12, 2021
Total Value ($000): $286,745 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VT | VANGUARD INTL EQUITY INDEX F | 1,104,408 | $102,246 | 35.7% | $92.58 | — | TT WRLD ST ETF | 922042742 |
| VSS | VANGUARD INTL EQUITY INDEX F | 487,765 | $59,429 | 20.7% | $121.84 | — | FTSE SMCAP ETF | 922042718 |
| IUSV | ISHARES TR | 726,403 | $45,175 | 15.8% | $54.29 | — | CORE S&P US VLU | 464287663 |
| HYG | ISHARES TR | 414,440 | $36,181 | 12.6% | $83.73 | — | IBOXX HI YD ETF | 464288513 |
| ICVT | ISHARES TR | 172,253 | $16,631 | 5.8% | $96.55 | — | CONV BD ETF | 46435G102 |
| EDV | VANGUARD WORLD FD | 97,773 | $14,891 | 5.2% | $152.30 | — | EXTENDED DUR | 921910709 |
| BKLN | INVESCO EXCH TRADED FD TR II | 467,191 | $10,409 | 3.6% | $22.28 | — | SR LN ETF | 46138G508 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 34,350 | $1,141 | 0.4% | $38.42 | +5.4% | COM | 71722W107 |
| — | AKERO THERAPEUTICS INC | 14,891 | $384 | 0.1% | $25.79 | — | COM | 00973Y108 |
| — | GENERATION BIO CO | 9,113 | $258 | 0.1% | $28.31 | — | COM | 37148K100 |